Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rajan, Sujeet
NCT04533022 / 2020-000822-24: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF May 2023 - May 2023 : Safety and efficacy of AIR study in idiopathic pulmonary fibrosis Interim data from AIR STUDY for IPF Nov 2022 - Nov 2022: Interim data from AIR STUDY for IPF Interim data from AIR STUDY for IPF Feb 2022 - Feb 2022: Interim data from AIR STUDY for IPF	Completed	2	52	Europe, RoW	C21	Vicore Pharma AB, Orphan Reach	Idiopathic Pulmonary Fibrosis	03/24	03/24